Mydekla 60 Tablet

Introduction

Mydekla is a prescription medication that contains the active ingredient Daclatasvir. It is commonly prescribed for the treatment of certain types of hepatitis C virus (HCV) infections. This medication is available under the brand name Mydekla.

Uses

Mydekla is primarily used to treat chronic hepatitis C infections caused by specific genotypes of the virus. It is used in combination with other antiviral medications to help eliminate the virus from the body and reduce the risk of liver damage, cirrhosis, and liver cancer associated with HCV infections.

Dosage and Administration

The dosage of Mydekla may vary depending on the individual’s specific condition and medical history. Follow the instructions provided by your healthcare provider. Typically, the recommended dose for adults is one tablet taken orally once daily with or without food. The duration of treatment may also vary and is usually determined by your healthcare provider.

Mechanism of Action

Mydekla belongs to a class of medications known as direct-acting antivirals (DAAs). It works by inhibiting the replication of the hepatitis C virus, preventing its spread throughout the body. Daclatasvir specifically targets a protein called NS5A, which is essential for the replication of the virus. By blocking NS5A, Mydekla helps to reduce the viral load and restore liver function.

Side Effects

Common side effects may include headache, fatigue, nausea, diarrhea, and difficulty sleeping. These side effects are generally mild and temporary.

However, some individuals may experience more serious side effects. If you experience any of the following symptoms, seek immediate medical attention: severe allergic reactions (such as rash, itching, swelling, severe dizziness), signs of liver problems (such as yellowing of the skin/eyes, dark urine, persistent nausea/vomiting, stomach/abdominal pain), or signs of anemia (such as unusual tiredness, pale skin).

Drug Interactions

inform your healthcare provider about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. Mydekla may interact with certain medications, such as those used to treat HIV or tuberculosis. These interactions can affect the effectiveness of the medication or increase the risk of side effects. Your healthcare provider will carefully assess your medication regimen to ensure safe and effective use of Mydekla.

Precautions

Before starting Mydekla, inform your healthcare provider about any pre-existing medical conditions, including liver problems, kidney problems, or any allergies. This medication may not be suitable for everyone and may have specific contraindications or precautions.

Mydekla should not be used during pregnancy or while breastfeeding, as it may harm the unborn baby or pass into breast milk. Additionally, avoid alcohol consumption while taking this medication, as it may increase the risk of liver damage.

Storage

Patient Tips

• Take Mydekla exactly as prescribed by your healthcare provider. Do not change the dosage or stop taking the medication without consulting your doctor.
• take Mydekla consistently and at the same time each day to maintain steady levels of the medication in your body.
• If you miss a dose, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• Follow any additional instructions provided by your healthcare provider, such as dietary restrictions or lifestyle modifications to support the effectiveness of the medication.
• Keep all follow-up appointments with your healthcare provider to monitor your progress and ensure the medication is working effectively.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Daclatasvir (Drugs.com) [Accessed 29 Jun. 2024] (online) Available at:
• daclatasvir tablet (RX) [Accessed 8 Jun. 2024] (online) Available at:
• Daclatasvir (MedlinePlus) [Accessed 12 Jun. 2024] (online) Available at:
• Gandhi Y, Eley T, Fura A, Li W, Bertz RJ, Garimella T. Daclatasvir: A Review of Preclinical and Clinical Pharmacokinetics. Clin Pharmacokinet. 2018 Aug;57(8):911-928. doi: 10.1007/s40262-017-0624-3. [Accessed 19 Jun. 2024] Available at: